Peer-Reviewed Article March 2, 2016
Recent advances in 4-aminoquinazoline based scaffold derivatives targeting EGFR kinases as anticancer agents
Are you an author of this work?Link to your sovereign AfriScholar profile
Published in: Future Journal of Pharmaceutical Sciences
Publisher: Springer Science+Business Media • Egypt • 2314-7245
Abstract
Quinazoline derivatives are fused heterocyclic ring systems which have been explored for their inhibitory activity towards various protein kinase enzymes and their role as anticancer agents. The present review to represent the most recent synthetic strategies and medicinal aspects including structure activity relationships of substituted quinazolines as EGFR inhibitors reported to date.
